Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

September 13, 2005; 65 (5) Articles

NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients

Z. Sahenk, H. N. Nagaraja, B. S. McCracken, W. M. King, M. L. Freimer, J. M. Cedarbaum, J. R. Mendell
First published July 6, 2005, DOI: https://doi.org/10.1212/01.WNL.0000171978.70849.c5
Z. Sahenk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. N. Nagaraja
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. S. McCracken
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. M. King
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. L. Freimer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. M. Cedarbaum
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. R. Mendell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients
Z. Sahenk, H. N. Nagaraja, B. S. McCracken, W. M. King, M. L. Freimer, J. M. Cedarbaum, J. R. Mendell
Neurology Sep 2005, 65 (5) 681-689; DOI: 10.1212/01.WNL.0000171978.70849.c5

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
962

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Information

vol. 65 no. 5 681-689
DOI: 
https://doi.org/10.1212/01.WNL.0000171978.70849.c5
PubMed: 
16157899

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published July 6, 2005.

Article Versions

  • Previous version (July 6, 2005 - 12:53).
  • You are viewing the most recent version of this article.
Copyright & Usage: 
© 2005

Author Disclosures

    1. Z. Sahenk, MD, PhD,
    2. H. N. Nagaraja, PhD,
    3. B. S. McCracken, CCRC,
    4. W. M. King, PT,
    5. M. L. Freimer, MD,
    6. J. M. Cedarbaum, MD and
    7. J. R. Mendell, MD
  1. Z. Sahenk, MD, PhD,
  2. H. N. Nagaraja, PhD,
  3. B. S. McCracken, CCRC,
  4. W. M. King, PT,
  5. M. L. Freimer, MD,
  6. J. M. Cedarbaum, MD and
  7. J. R. Mendell, MD
  1. From the Departments of Neurology (Drs. Sahenk, McCracken, King, Freimer, and Mendell), Pediatrics (Drs. Sahenk and Mendell), and Statistics (Dr. Nagaraja), Ohio State University, Columbus; and Regeneron Pharmaceuticals, Inc. (Dr. Cedarbaum), Tarrytown, NY.
  1. Address correspondence and reprint requests to Dr. Z. Sahenk, Columbus Children’s Research Institute, Molecular Medicine Division, 700 Children’s Drive, Room WA 3024, Columbus, OH 43205; e-mail: Sahenk.1{at}osu.edu
View Full Text

Article usage

Article usage: July 2005 to March 2021

AbstractFullPdfSource
Jul 2005113050Highwire
Aug 200575043Highwire
Sep 2005383202182Highwire
Oct 20059514197Highwire
Nov 2005548734Highwire
Dec 2005696332Highwire
Jan 2006651216Highwire
Feb 200615636Highwire
Mar 200691311Highwire
Apr 20063313Highwire
May 20061918Highwire
Jun 20062147Highwire
Jul 20061703Highwire
Aug 20061418Highwire
Sep 20061759Highwire
Oct 20061748Highwire
Nov 20062911Highwire
Dec 20061456Highwire
Jan 20071913Highwire
Feb 20071518Highwire
Mar 20072526Highwire
Apr 20071535Highwire
May 20073269Highwire
Jun 20072645Highwire
Jul 20071799Highwire
Aug 20072054Highwire
Sep 200720105Highwire
Oct 20071568Highwire
Nov 20072732Highwire
Dec 20072254Highwire
Jan 20082533Highwire
Feb 20081559Highwire
Mar 200822313Highwire
Apr 20081734Highwire
May 20082076Highwire
Jun 20081976Highwire
Jul 20085155Highwire
Aug 20083412Highwire
Sep 200824107Highwire
Oct 20083745Highwire
Nov 20081932Highwire
Dec 20081643Highwire
Jan 20092064Highwire
Feb 20092357Highwire
Mar 20092452Highwire
Apr 20091821Highwire
May 20092322Highwire
Jun 20093169Highwire
Jul 20092458Highwire
Aug 20093033Highwire
Sep 20092347Highwire
Oct 20092558Highwire
Nov 20092521Highwire
Dec 20093423Highwire
Jan 20103001Highwire
Feb 20102111Highwire
Mar 20103778Highwire
Apr 20102134Highwire
May 20101933Highwire
Jun 20102312Highwire
Jul 20102723Highwire
Aug 20103521Highwire
Sep 20102511Highwire
Oct 20101975Highwire
Nov 2010432Highwire
Dec 20101874Highwire
Jan 20112755Highwire
Feb 20113556Highwire
Mar 20113744Highwire
Apr 20113732Highwire
May 20112853Highwire
Jun 20112720Highwire
Jul 20111621Highwire
Aug 20112975Highwire
Sep 20111472Highwire
Oct 20112022Highwire
Nov 20113424Highwire
Dec 20112642Highwire
Jan 20123334Highwire
Feb 20122332Highwire
Mar 20122210Highwire
Apr 20121800Highwire
May 20122732Highwire
Jun 20122855Highwire
Jul 20123635Highwire
Aug 2012993Highwire
Sep 20121512Highwire
Oct 20121910Highwire
Nov 20122400Highwire
Dec 20121812Highwire
Jan 20132711Highwire
Feb 20132812Highwire
Mar 20131684Highwire
Apr 20132623Highwire
May 20131024Highwire
Jun 20131420Highwire
Jul 20131211Highwire
Aug 20131900Highwire
Sep 20132542Highwire
Oct 20131243Highwire
Nov 20132344Highwire
Dec 20131132Highwire
Jan 20142412Highwire
Feb 20142710Highwire
Mar 20141132Highwire
Apr 20142234Highwire
May 20141310Highwire
Jun 20142323Highwire
Jul 20142221Highwire
Aug 20142422Highwire
Sep 2014842Highwire
Oct 20141912Highwire
Nov 20141720Highwire
Dec 20141410Highwire
Jan 20152300Highwire
Feb 20151411Highwire
Mar 20152723Highwire
Apr 20151710Highwire
May 20151700Highwire
Jun 2015901Highwire
Jul 2015421Highwire
Aug 2015921Highwire
Sep 2015932Highwire
Oct 20151144Highwire
Nov 20151443Highwire
Dec 20151710Highwire
Jan 20162412Highwire
Feb 20162001Highwire
Mar 20162210Highwire
Apr 2016700Highwire
May 20161210Highwire
Jun 2016800Highwire
Jul 20161700Highwire
Aug 20161010Highwire
Sep 20161911Highwire
Oct 20161500Highwire
Nov 20162200Highwire
Dec 20161600Highwire
Jan 20171700Highwire
Feb 20171321Highwire
Mar 20172211Highwire
Apr 20171300Highwire
May 20171820Highwire
Jun 20171600Highwire
Jul 20171920Highwire
Aug 2017922Highwire
Sep 20171741Highwire
Oct 20172521Highwire
Nov 20171400Highwire
Dec 20171300Highwire
Jan 20181700Highwire
Feb 20182440Highwire
Mar 20183111Highwire
Apr 20182962Highwire
May 20182421Highwire
Jun 20182433Highwire
Jul 20182534Highwire
Aug 20182700Highwire
Sep 20181900Highwire
Oct 201811622Highwire
Nov 20185942Highwire
Dec 20189721Highwire
Jan 20194232Highwire
Feb 20195230Highwire
Mar 20195644Highwire
Apr 20196800Highwire
May 20195372Highwire
Jun 20193502Highwire
Jul 20192021Highwire
Aug 20194384Highwire
Sep 20195122Highwire
Oct 20195713Highwire
Nov 20194022Highwire
Dec 20195622Highwire
Jan 20205163Highwire
Feb 20201801Highwire
Mar 20203954Highwire
Apr 20203231Highwire
May 20205053Highwire
Jun 20204731Highwire
Jul 20202912Highwire
Aug 20201201Highwire
Sep 20205203Highwire
Oct 20203534Highwire
Nov 20202842Highwire
Dec 20204103Highwire
Jan 20216256Highwire
Feb 20216266Highwire
Mar 20214424Highwire

Cited By...

  • 104 Citations
  • Google Scholar

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Methods.
    • Results.
    • Discussion.
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • Neurotrophin-3 therapy for Charcot–Marie–Tooth disease type 1A

Alert Me

  • Alert me when eletters are published
Neurology: 96 (15)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise